Skip to content

SG&A at other companies

Labcorp Holdings logo
Labcorp HoldingsLH
$551M+0.9%
Illumina logo
IlluminaILMN
$272M+1.9%
Natera, Inc. logo
Natera, Inc.NTRA
$327.94M+22.9%
Revvity logo
RevvityRVTY
$253.88M+1.7%
GeneDx Holdings logo
GeneDx HoldingsWGS
$74.59M+47.9%
ImmunityBio, Inc. logo
ImmunityBio, Inc.IBRX

Other financials

Income statement

See full
Revenue$108.4M+83.8%
Gross profit$79.1M+108%
Operating income$17.8M+870%
Net income$18.0M+551%
EPS (diluted)$0.34+187%

Balance sheet

See full
Cash & equivalents$537.5M+181%
Total debt$144.2M
Total equity$505.6M+300%
Total assets$700.7M

Cash flow

See full
Operating cash flow$15.4M+488%
CapEx$4.5M+90.5%
Free cash flow$11.0M+3,842%

Valuation

See full
Market cap$4.96B

Profitability

See full
Gross margin70.4%
Operating margin-96.9%
Net margin8.4%
FCF margin-83.4%

Returns & leverage

See full
Debt / equity0.3×
Current ratio10.9×

Where this comes from

Reported directly by BillionToOne, Inc. in its filing.

Tagged under the XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense.

The official record: BillionToOne, Inc. ’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about BillionToOne, Inc. 's sg&a.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is BillionToOne, Inc. 's SG&A?
BillionToOne, Inc. (BLLN) reported SG&A of $46.57M in Q1 2026.
How has BillionToOne, Inc. 's SG&A changed year-over-year?
BillionToOne, Inc. 's SG&A increased by 56.0% year-over-year, from $29.86M to $46.57M.
What does SG&A mean?
Combined selling expenses (sales force, marketing, distribution) and general & administrative costs (management, legal, accounting, facilities) — the broadest opex category.